Pharmaceutical care until the end: the role of pharmacists in euthanasia in the Netherlands N.J. Naafs Commentary Pages: 129 - 131
Long term therapy with spironolactone Marcel L. BouvyEibert R. HeerdinkRon M.C. Herings Legacy Pages: 132 - 134
The introduction of pharmacoeconomic analysis in Norway ― are the users prepared? Elisabeth Moen RørvikElse-Lydia ToverudLars. Walløe Legacy Pages: 135 - 144
Number of non‐diabetic drugs: a simple comorbidity indicator for diabetes? P. M. WhittyM. P EcclesJ. Hewison Legacy Pages: 145 - 147
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease D.A.M.C. van de VijverA.J. PorsiusJ. Hewison Legacy Pages: 148 - 152
Polypharmacy among patients admitted to hospital with rheumatic diseases Kirsten K. ViktilMerethe EnstadJan Schjott Legacy Pages: 153 - 158
The role of the Danish community pharmacist: perceptions and future scenarios Lotte Stig NørgaardLene ColbergMie Riise Niemann Legacy Pages: 159 - 164
